Abstract
Purpose
Preference-based health measures value how people feel about the desirability of a health state. Generic measures may not
effectively capture the impact of vision loss from ocular diseases. Disease-targeted measures could address this limitation.
This study developed a vision-targeted health state classification system based on the National Eye Institute Visual Function
Questionnaire-25 (NEI VFQ-25).
effectively capture the impact of vision loss from ocular diseases. Disease-targeted measures could address this limitation.
This study developed a vision-targeted health state classification system based on the National Eye Institute Visual Function
Questionnaire-25 (NEI VFQ-25).
Methods
Secondary analysis of NEI VFQ-25 data from studies of patients with central (n = 932)- and peripheral-vision loss (n = 2,451) were used to develop a health state classification system. Classical test theory and Rasch analyses were used to
identify a smaller set of NEI VFQ-25 items suitable for the central- and peripheral-vision-loss groups.
identify a smaller set of NEI VFQ-25 items suitable for the central- and peripheral-vision-loss groups.
Results
Rasch analysis of the NEI VFQ-25 items using the peripheral vision–loss data indicated that 11 items fit a unidimensional
model, while 14 NEI VFQ-25 items fit using the central-vision-loss data. Combining peripheral-vision-loss data and central-vision-loss
data resulted in 9 items fitting a unidimensional model. Six items covering near vision, distance vision, social vision, role
difficulties, vision dependency, and vision-related mental health were selected for the health-state classification.
model, while 14 NEI VFQ-25 items fit using the central-vision-loss data. Combining peripheral-vision-loss data and central-vision-loss
data resulted in 9 items fitting a unidimensional model. Six items covering near vision, distance vision, social vision, role
difficulties, vision dependency, and vision-related mental health were selected for the health-state classification.
- Content Type Journal Article
- Pages 1-12
- DOI 10.1007/s11136-011-9938-z
- Authors
- Jonathan W. Kowalski, Global Health Outcomes Strategy and Research, Allergan Inc, 2525 Dupont Drive, Irvine, CA 92612, USA
- Anne M. Rentz, United BioSource Corporation, Bethesda, MD, USA
- John G. Walt, Medical Affairs, Allergan Inc, 2525 Dupont Drive, Irvine, CA 92612, USA
- Andrew Lloyd, Oxford Outcomes, Oxford, UK
- Jeff Lee, Payer and Health Outcomes Regional Scientific Services, Allergan Inc, 2525 Dupont Drive, Irvine, CA 92612, USA
- Tracey A. Young, University of Sheffield, Sheffield, UK
- Wen-Hung Chen, United BioSource Corporation, Bethesda, MD, USA
- Neil M. Bressler, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Paul Lee, Duke University, Durham, NC, USA
- John E. Brazier, University of Sheffield, Sheffield, UK
- Ron D. Hays, University of California-Los Angeles, Los Angeles, CA, USA
- Dennis A. Revicki, United BioSource Corporation, Bethesda, MD, USA
- Journal Quality of Life Research
- Online ISSN 1573-2649
- Print ISSN 0962-9343